DEUTSCHE BANK AG\ - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 247 filers reported holding SAGE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$21,162,435
-56.5%
1,028,301
-0.6%
0.01%
-46.2%
Q2 2023$48,653,522
+49.2%
1,034,741
+33.1%
0.03%
+44.4%
Q1 2023$32,620,249
+62.0%
777,413
+47.3%
0.02%
+50.0%
Q4 2022$20,134,831
-8.0%
527,919
-5.5%
0.01%
-7.7%
Q3 2022$21,885,000
+19.3%
558,868
-1.6%
0.01%
+30.0%
Q2 2022$18,346,000
-4.3%
567,957
-2.0%
0.01%
+11.1%
Q1 2022$19,177,000
-25.8%
579,342
-4.6%
0.01%
-25.0%
Q4 2021$25,828,000
-7.8%
607,142
-3.9%
0.01%
-7.7%
Q3 2021$28,009,000
-18.8%
632,087
+4.1%
0.01%
-23.5%
Q2 2021$34,480,000
-28.3%
606,910
-5.5%
0.02%
-34.6%
Q1 2021$48,093,000
-22.4%
642,537
-10.3%
0.03%
-31.6%
Q4 2020$61,946,000
+268.8%
716,065
+160.5%
0.04%
+216.7%
Q3 2020$16,798,000
+27.6%
274,837
-13.2%
0.01%
+20.0%
Q2 2020$13,168,000
+4.3%
316,695
-28.0%
0.01%
-9.1%
Q1 2020$12,624,000
-51.5%
439,558
+22.0%
0.01%
-35.3%
Q4 2019$26,003,000
+48.7%
360,244
+189.0%
0.02%
+41.7%
Q3 2019$17,486,000
-34.8%
124,654
-14.9%
0.01%
-25.0%
Q2 2019$26,815,000
+112.6%
146,480
+84.6%
0.02%
+100.0%
Q1 2019$12,614,000
-3.8%
79,333
-42.1%
0.01%
-11.1%
Q4 2018$13,113,000
-69.9%
136,920
-55.7%
0.01%
-30.8%
Q3 2018$43,631,000
-18.7%
308,900
-9.9%
0.01%
-13.3%
Q2 2018$53,636,000
+9.6%
342,669
+12.8%
0.02%
-34.8%
Q1 2018$48,945,000
+95.8%
303,895
+100.2%
0.02%
+43.8%
Q4 2017$24,996,000
+6.0%
151,779
-59.9%
0.02%0.0%
Q3 2017$23,584,000
-55.2%
378,619
-42.7%
0.02%
-57.9%
Q2 2017$52,592,000
+9.8%
660,413
-2.0%
0.04%
+8.6%
Q1 2017$47,888,000
+3.8%
673,871
-25.4%
0.04%
-5.4%
Q4 2016$46,136,000
-3.0%
903,635
-12.5%
0.04%
+8.8%
Q3 2016$47,542,000
+278.4%
1,032,426
+147.6%
0.03%
+277.8%
Q2 2016$12,563,000
+33.0%
417,012
+41.6%
0.01%
+28.6%
Q1 2016$9,443,000
+312.5%
294,571
+650.0%
0.01%
+250.0%
Q4 2015$2,289,000
+201.2%
39,278
+118.2%
0.00%
+100.0%
Q3 2015$760,000
-49.6%
17,998
-13.0%
0.00%0.0%
Q2 2015$1,508,000
+36.1%
20,678
-6.3%
0.00%0.0%
Q1 2015$1,108,000
+139.3%
22,073
+74.1%
0.00%
Q4 2014$463,000
-17.3%
12,678
-28.8%
0.00%
Q3 2014$560,00017,8010.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders